TECN logo
TECN
Tecan Group

Advanced Automation And Personalized Medicine Will Shape Healthcare's Future

Published
16 Mar 25
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
CHF 223.02
23.5% undervalued intrinsic discount
14 Aug
CHF 170.60
Loading
1Y
-40.7%
7D
10.3%

Author's Valuation

CHF 223.0

23.5% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Narrative
Updates7

Shared on01 May 25
Fair value Decreased 6.89%

Read more

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on02 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on26 Mar 25
Fair value Decreased 0.083%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on19 Mar 25
Fair value Increased 6.53%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more